On September 5, 2019 CollPlant (NASDAQ: CLGN), a regenerative medicine company, reported that Yehiel Tal, Chief Executive Officer will be presenting at the 21st Annual Global Rodman and Renshaw Investment Conference, sponsored by H. C. Wainwright, at the Lotte New York Palace Hotel in New York on Tuesday, September 10th, 2019 at 1:45 pm EDT (Press release, CollPlant, SEP 5, 2019, View Source;renshaw-global-investment-conference-300912408.html [SID1234539327]). Mr. Tal will provide an overview of the Company’s business, including in the fields of medical aesthetics, breast implants and 3D bioprinting of life saving organs. Institutional investors and analysts that are attending the conference may request a one-on-one meeting through the conference coordinators.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: 21st Annual Rodman & Renshaw Global Investment Conference
Date: September 10, 2019
Time: 1:45 -2:10 pm (Eastern Time)
Location: Holmes II Room, St Lotte New York Palace Hotel in New York City